Children's Tumor Foundation President and Chief Scientific Officer Annette Bakker, PhD, addressed the attendees at the annual NF Conference Welcome Dinner on Saturday, June 10, 2017 at the National Press Club in Washington, DC. Dr. Bakker spoke to the nearly 400 attendees about the importance of disease-focused research, the advantages of team science, and the development of an infrastructure intended to bring biotech and pharmaceutical companies to the NF table. She highlighted CTF's innovative research model, and its tremendous potential for further application to other rare disease, as well as cancer research. The NF Conference is the premier gathering of scientists and clinicians from around the world dedicated to advancing research and care for those living with NF.
Greg Simon, Director, Biden Cancer Initiative, was the Keynote Speaker at the 2017 NF Conference Welcome Dinner on Saturday, June 10, 2017. The NF Conference is the premier gathering of scientists and clinicians from around the world dedicated to advancing research and care for those living with NF. Mr. Simon addressed the nearly 400 attendees on the topics of research collaboration and breaking down barriers to research progress. Introducing Mr Simon is Annette Bakker, PhD, Children's Tumor Foundation President and Chief Scientific Officer. Click thru to view his presentation.
Last year, the Children's Tumor Foundation announced Synodos for NF1, a unique consortium bringing together a multidisciplinary team of scientists, clinicians, technicians, patients and other experts from world-class labs at academic and medical centers. These scientists have pledged to work together and share unpublished information, datasets, and results, thereby accelerating the drug development process.
Like the rest of the NF community, we are stunned after watching this week’s episode of “Scream Queens”, titled “Warts & All.” In addition to providing escape and entertainment, television shows have the capacity to teach and make the audience feel something. However, this show needlessly elicited pain and anger in a community seeking nothing more than kindness and acceptance.
The Children’s Tumor Foundation and the Gilbert Family Neurofibromatosis Institute proudly announce the Optic Pathway Glioma (OBG) Consortium, a five-year collaboration involving 25 NF clinics in a study of OPG in children with neurofibromatosis type 1 (NF1).